A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 17
[Display Entries]
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : MEAs
Long Form : managed entry agreements
No. Year Title Co-occurring Abbreviation
2020 A MEA is a MEA is a MEA? Sequential decision making and the impact of different managed entry agreements at the manufacturer and payer level, using a case study for an oncology drug in England. CE, DCF, LTTACC, MBG, NMB, PSUB, SDM, TOT, VoI
2020 An evaluation of managed entry agreements in Belgium: A system with threats and (high) potential if properly applied. ---
2020 Exploring the status and views of managed entry agreements in Saudi Arabia: mixed-methods approach. ---
2020 Integrative Review of Managed Entry Agreements: Chances and Limitations. ---
2020 Managed Entry Agreements: Policy Analysis From the European Perspective. CED, FBAs
2020 The impact of managed entry agreements on pharmaceutical prices. ---
2018 Access to innovative medicines for metastatic melanoma worldwide: Melanoma World Society and European Association of Dermato-oncology survey in 34 countries. ESMO, HEpc, HTA
2018 CHARACTERISTICS OF MANAGED ENTRY AGREEMENTS IN AUSTRALIA. ATC, HTA, MIPs, PBS
2018 Establishing the cost of implementing a performance-based, managed entry agreement for a hypothetical CAR T-cell therapy. SOC
10  2017 The assessment and appraisal of regenerative medicines and cell therapy products: an exploration of methods for review, economic evaluation and appraisal. CAR, NICE, TPPs
11  2017 The HTA Risk Analysis Chart: Visualising the Need for and Potential Value of Managed Entry Agreements in Health Technology Assessment. HTA, NICE, P-SUB, PSB, PUB
12  2017 The Implementation of Managed Entry Agreements in Central and Eastern Europe: Findings and Implications. ATC, CEE
13  2017 The value of innovation in decision-making in health care in Central Eastern Europe - The Sixth International Conference, 2 June 2017, Belgrade, Serbia. ---
14  2015 MONITORING REGISTRIES AT ITALIAN MEDICINES AGENCY: FOSTERING ACCESS, GUARANTEEING SUSTAINABILITY. ---
15  2014 Health economic value of an innovation: delimiting the scope and framework of future market entry agreements. ---
16  2013 Reconciling uncertainty of costs and outcomes with the need for access to orphan medicinal products: a comparative study of managed entry agreements across seven European countries. OMPs
17  2011 What principles should govern the use of managed entry agreements? HTAi